✦ LIBER ✦

Balancing efficacy and safety of JAK inhibitors in myelofibrosis

✍ Scribed by Passamonti, Francesco

Book ID: 122172939
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 183 KB
Volume: 38
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.12.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of INCB018424, a JAK

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

✍ Verstovsek, Srdan; Kantarjian, Hagop; Mesa, Ruben A.; Pardanani, Animesh D.; Cor 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 542 KB

Safety and efficacy of CYT387, a JAK1 an

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

✍ Pardanani, A; Laborde, R R; Lasho, T L; Finke, C; Begna, K; Al-Kali, A; Hogan, W 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 510 KB

Ruxolitinib, an oral JAK1 and JAK2 inhib

Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis

✍ Vaddi, Kris; Sarlis, Nicholas J; Gupta, Vikas 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 545 KB

JAK inhibitor therapy for myelofibrosis:

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations

✍ Pardanani, A; Vannucchi, A M; Passamonti, F; Cervantes, F; Barbui, T; Tefferi, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 316 KB

Allogeneic hematopoietic cell transplant

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

✍ Jaekel, N; Behre, G; Behning, A; Wickenhauser, C; Lange, T; Niederwieser, D; Al- 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 313 KB

Balancing safety and efficacy in the tre

Balancing safety and efficacy in the treatment of pediatric asthma

✍ Graham, LeRoy M. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 128 KB